Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Total article views   HTML views PDF downloads Totals
3,451 Dovepress* 3,275+ 373 3,648
PubMed Central* 176 76 252
Totals 3,451 449 3,900
*Since 30 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar